Vistagen (VTGN) analyst forecast and price target
Analyst forecast
Consensus of 2 analyst ratings
Recent analyst ratings
| Firm | Action | Rating | Price target | Date |
|---|---|---|---|---|
| Jefferies | Downgraded | Buy → Hold | $0.90 from $15.00 | Dec 17, 2025 |
| Maxim Group | Downgraded | Buy → Hold | — | Dec 17, 2025 |
| William Blair | Downgraded | Outperform → Market Perform | — | Dec 17, 2025 |
| Jefferies | Upgraded | Hold → Buy | $15.00 from $0.20 | Dec 7, 2023 |
| Stifel | Initiated Coverage | Buy | $12.00 | Nov 14, 2023 |
| Maxim Group | Maintained | Buy | $30.00 | Sep 5, 2023 |
| Maxim Group | Upgraded | Hold → Buy | $30.00 | Aug 7, 2023 |
Frequently asked questions
Is VTGN a buy, sell, or hold?
Analysts covering Vistagen currently average a Hold rating: 0 buy, 2 hold and 0 sell, from 2 analysts. Ratings reflect analyst opinion, not investment advice.
What is the latest analyst rating on VTGN?
On Dec 17, 2025, Jefferies downgraded Vistagen to Hold with a price target of $0.90.
Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.